Form 4 · Filed Jun 16, 2026, 09:07 PM UTC
CGON/CG Oncology, Inc.
Mulay James — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | M | other | 654 | $4 | $2,433 | 654 |
| Jun 15, 2026 | S | sell | 654 | $60 | $39,318 | 0 |
| Jun 15, 2026 | M | other | 1,310 | $13 | $16,493 | 1,310 |
| Jun 15, 2026 | S | sell | 1,310 | $60 | $78,757 | 0 |
| Jun 15, 2026 | M | other | 654 | — | — | 0 |
| Jun 15, 2026 | M | other | 1,310 | — | — | 2,620 |
Source: SEC EDGAR raw filing ↗ · Accession 0001684531-26-000002